Feasibility Study of Sleep Endoscopy Under Hypnosis in a Sleep Center
NCT ID: NCT05091164
Last Updated: 2021-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2021-02-08
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate obstructive sleep apnea syndrome patient under hypnosis
Patients suffering from moderate obstructive sleep apnea syndrome. It is proposed to induce in the patient a hypnotic trance leading to intense muscle relaxation, capable of reproducing in the upper airways.
The type of collapsibility thus obtained, classified according to Kezirian (6), will allow specific management by OAM in the event of predominant anteroposterior stenosis.
Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis
Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis
Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate obstructive sleep apnea syndrome (Hypopnea apnea index between 15 and 30) without any serious sign
* Simple Ronchopathy
* Indication of video-fibroscopy of upper airways
* Affiliated subject or beneficiary of a social security scheme
* Patient having signed the free and informed consent
Exclusion Criteria
* Smoking less than 10 cigarettes per day
* Alcoholism, chronic or serious disabling pathology
* Medical history of cancer of upper airways, radiotherapy
* Pregnancy
* Recent supper airway infection, rhinosinusitis
* Active allergy
* Non-obstructive sleep apnea syndrome
* severe non-obstructive sleep apnea syndrome (Hypopnea apnea index\> 30)
* Dental contraindication to mandibular advancement device
* Intolerance or allergy to local anesthesia with Xylocaine spray 5% known
* Refusal to participate in the study
* Protected patients: adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
* Pregnant, breastfeeding or parturient woman
* Hospitalized without consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Clinical Trial Experts Network
OTHER
Polyclinique Poitiers
UNKNOWN
Elsan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre du Sommeil de la Polyclinique de Poitiers
Potiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A02419-30
Identifier Type: -
Identifier Source: org_study_id